Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Medivation Sends Letter to Stockholders to Set the Record Straight on Sanofi’s Misleading Claims

Medivation Inc. sent a letter to stockholders providing detailed information to correct the misleading claims Sanofi has made as part of its coercive efforts to acquire Medivation at an opportunistic, low price that substantially undervalues Medivation.

Read More »

San Francisco sets vote on soda tax amid battle on health warnings

San Francisco residents will have a second chance to vote on whether to tax soda after city officials added the measure to a November ballot that could result in more of the Bay Area being subject to the controversial levy.

Read More »

Razorfish Health Appoints David Paragamian to the Role of Managing Director

NEW YORK, June 21, 2016 /PRNewswire/ — David Paragamian has been named Managing Director for Razorfish Health, a division of Publicis Health, the largest healthcare communications group in the world. In his new role, effective immediately, Paragamian will be responsible for overseeing Razorfish Health businesses across North America, including offices in New York and Philadelphia. Paragamian will […]

Read More »

WHO to launch emergency yellow fever vaccination in Angola, Congo

The World Health Organization (WHO) said on it will launch emergency yellow fever vaccination campaigns along the border between Angola and Democratic Republic of Congo and in the Congolese capital Kinshasa next month.

Read More »

Exclusive: Analysis suggests Anthem deal could raise health costs

As questions mount over whether health insurer Anthem Inc.’s proposed $48 billion purchase of Cigna Corp will win U.S. antitrust approval, an exclusive analysis produced for Reuters suggests the merger could lead to higher costs for large companies offering workplace medical benefits.

Read More »

U.S. CDC spurns AstraZeneca nasal flu vaccine

AstraZeneca said it would take an $80 million writedown on stocks of its intranasal flu vaccine Flumist Quadrivalent after U.S. health authorities decided they would not use the product.

Read More »

Eleven Bio Restructures, Eliminates 70% of Workforce

Struggling Eleven Biotherapeutics announced it will eliminate 70 percent of its workforce in a restructuring strategy in an effort to keep moving forward with its eye therapies.

Read More »

Republican lawmakers approve $1.1 billion in new Zika funds

The U.S. House of Representatives agreed to $1.1 billion to fight the Zika virus, short-changing President Barack Obama’s $1.9 billion funding request and angering Democrats by making other cuts to pay for it.

Read More »

Supreme Court weighs review of canceled patent on prenatal test

Companies, trade groups and universities are among a broad coalition urging the U.S. Supreme Court to review the cancellation of a patent on a less risky form of prenatal testing.

Read More »

Intouch Solutions Hosts Event to Celebrate New York Expansion

NEW YORK (June 23, 2016) – Intouch Solutions, a leading marketing agency serving the pharmaceutical industry, hosted a special evening celebration on Friday, June 17, to commemorate its New York expansion into new, larger office space. The event, called ‘Celebration on 7th Avenue,’ brought together Intouch associates, clients, partners and other special guests to enjoy […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!


Ad Right Bottom